N-(r)-1-{3-(4-piperidyl)propionyl}-3-piperidylcarbonyl-2(s)-acetylamino-beta-alanine as fibrinogen receptor antagonist
CA 2248809 A1 · Owner: Yamanaka, Toshio · Inventors: Kato, Masayuki; Ohkubo, Mitsuru; Yamanaka, Toshio
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to .beta.-alanine derivative represented by formula (I), which is glycoprotein IIB/IIIa antagonist inhibitor of blood platelets , aggregation and inhibitor of the binding of fibrinogen to blood platelets to , processes for the preparation thereof to a pharmaceutical composition , comprising the same and to a method for the prevention and/or treatment of diseases indicated in the specification to a human being or an animal.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 12, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 12, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 12, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.